We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Highly Sensitive TARDIS Sniffs Out Cancer in Patient’s Blood

News   Aug 08, 2019 | Original story from Translational Genomics Research Institute (TGen)

 
Highly Sensitive TARDIS Sniffs Out Cancer in Patient’s Blood

Muhammed Murtaza, M.B.B.S., Ph.D., Assistant Professor and Co-Director of TGen's Center for Noninvasive Diagnostics. He also holds a joint appointment on the Research Faculty at Mayo Clinic in Arizona, and is one of the study's senior authors. Credit: Courtesy of TGen.

 
 
Advertisement
 

RELATED ARTICLES

Historical Bias Overlooks Genes That Are Related to COVID-19

News

Based on genome-wide experiments, the human body has 2,064 genes relevant to COVID-19. So why are researchers only studying 611 of them?

READ MORE

Key Questions and Answers About the UK's First Approved COVID-19 Vaccine

News

The UK government has announced that the COVID-19 vaccine BNT162b2 – developed by Pfizer and BioNTech – has been authorized for use. Here, we address some of the key questions you may have about this announcement.

READ MORE

New Genetic Risk Factor for Motor Neuron Disease Identified

News

A new genetic risk factor for Motor Neurone disease has been discovered. A neuroprotective drug is already in development and may be effective for those suffering from the disease.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Cancer Research Diagnostics

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE